Models
GLAND PHARMA LIMITEDGLANDPharmaceuticals & Biotechnology
812per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model812implied FY26 P/E 11.8× · EV/EBITDA 6.4×
Against CMP ₹2,928.0072.3%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3177%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
6691,097
52-week rangetraded range, a fact not a value
1,5743,042

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow2,312
PV of terminal value7,961
Enterprise value10,273
less net debt3,116
less non-controlling interest0
add non-operating investments0
Equity value13,389
÷ 16.50 crore shares812
77% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.

Free cash flow, filed and modelled · ₹ '000 crore

00011FY21: ₹376 croreFY21FY22: ₹279 croreFY22FY23: ₹143 croreFY23FY24: ₹607 croreFY24FY25: ₹530 croreFY25FY26: ₹541 croreFY26FY27: ₹470 croreFY27FY28: ₹531 croreFY28FY29: ₹600 croreFY29FY30: ₹678 croreFY30FY31: ₹767 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%8328819381,0091,097
10.50%782822869926995
11.00%739772812858914
11.50%701730763802847
12.00%669693721754792
The outlined cell is your model. Green figures sit above the CMP of ₹2,928.00; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P10608P50804P901,008
10th · 50th · 90th percentile, ₹ per share608 · 804 · 1,008
Draws below the CMP100%
Rank correlation with ebitda margin+0.90
Rank correlation with discount rate0.35
Rank correlation with revenue growth0.18
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue3,6255,6655,6176,4317,3638,4319,65311,05312,656
growth %(17.6)56.3(0.9)14.514.514.514.514.514.5
EBITDA9681,3331,2691,6051,8412,1082,4132,7633,164
margin %26.723.522.625.025.025.025.025.025.0
less depreciation(147)(345)(378)(424)(486)(556)(637)(729)(835)
EBIT8229898911,1821,3551,5511,7762,0342,329
less tax on EBIT(353)(405)(464)(531)(608)(696)
NOPAT8289501,0871,2451,4261,632
add depreciation147345378424486556637729835
less capex(221)(390)(385)(491)(560)(647)(749)(867)(1,002)
less working-capital build(407)(465)(533)(610)(699)
Free cash flow to firm143607530470531600678767
Discount factor0.9490.8550.7700.6940.625
Present value446454462471479
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 243, dividends at 28.9% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT1,1821,3551,5511,7762,0342,329
Interest at 13% on debt(32)(32)(32)(32)(32)
Profit before tax1,3231,5201,7452,0022,297
Profit after tax1,0279281,0651,2231,4031,610
Dividends(297)(268)(308)(353)(406)(465)
Balance sheet, year end
Cash3,3593,5383,7393,9644,2144,493
Working capital2,8013,2083,6734,2064,8175,515
Net block and other assets6,3506,4246,5156,6276,7646,931
Debt243243243243243243
Equity10,35811,01711,77512,64413,64214,787
Balance check0(0)(0)(0)(0)(0)
Cash flow
From operations1,0071,1561,3271,5231,747
Investing (capex)(560)(647)(749)(867)(1,002)
Financing (dividends)(268)(308)(353)(406)(465)
Net change in cash179201225251279
Free cash flow to equity447509578656744
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF14.5%25%11.00%5%812(72.3)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.